Media: Lack of buyers' interest in Novo Holdings-owned Xellia Pharmaceuticals

Novo Holdings’ hopes of selling antibiotics producer Xellia Pharmaceuticals have run aground, Danish business daily Børsen has learned.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Holdings appoints new CFO
For subscribers